Literature DB >> 7758176

Angiotensin-converting enzyme I/D polymorphism and arterial wall thickness in a general population. The Vobarno Study.

M Castellano1, M L Muiesan, D Rizzoni, M Beschi, G Pasini, A Cinelli, M Salvetti, E Porteri, G Bettoni, R Kreutz.   

Abstract

BACKGROUND: It has been reported that the D allele of an insertion/deletion (I/D) polymorphism of the angiotensin I-converting enzyme (ACE) gene is associated with conditions of increased cardiovascular risk, including left ventricular hypertrophy. METHODS AND
RESULTS: Considering that a genetically determined overactivity of the renin-angiotensin system may influence cardiac as well as vascular growth, we investigated possible relations between ACE I/D genotype and carotid artery wall thickness (B-mode ultrasound) in 199 subjects, 50 to 64 years old, sampled from the general population of Vobarno, a small town in northern Italy. ACE DD genotype was associated with significantly higher common carotid artery intima-media thickness (P = .003). The occurrence of carotid atherosclerotic plaques was similar in the different genotypes. There was no association of the ACE I/D genotype with blood pressure values (either casual of 24-hour ambulatory monitored).
CONCLUSIONS: ACE DD genotype may be considered a risk factor for the development of common carotid intima-media thickening in our study population.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7758176     DOI: 10.1161/01.cir.91.11.2721

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  20 in total

Review 1.  Angiotensin I-converting enzyme: genotype and disease associations.

Authors:  D Crisan; J Carr
Journal:  J Mol Diagn       Date:  2000-08       Impact factor: 5.568

Review 2.  Genetic determinants of vascular reactivity.

Authors:  Daniel Henrion; Joelle Benessiano; Marc Iglarz; Ivan Philip; Bernard I Levy
Journal:  Curr Hypertens Rep       Date:  2002-02       Impact factor: 5.369

3.  Increased amount of the angiotensin-converting enzyme (ACE) mRNA originating from the ACE allele with deletion.

Authors:  Tadashi Suehiro; Tatsuhito Morita; Mari Inoue; Yoshitaka Kumon; Yukio Ikeda; Kozo Hashimoto
Journal:  Hum Genet       Date:  2004-05-26       Impact factor: 4.132

4.  Should the contribution of ACE gene polymorphism to left ventricular hypertrophy be reconsidered?

Authors:  H Montgomery
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

5.  Angiotensin-converting enzyme insertion/deletion gene polymorphism in cystic fibrosis patients.

Authors:  Sabrine Oueslati; Sondess Hadj Fredj; Hajer Siala; Amina Bibi; Hajer Aloulou; Lamia Boughamoura; Khadija Boussetta; Sihem Barsaoui Barsaoui; Taieb Messaoud
Journal:  J Genet       Date:  2016-03       Impact factor: 1.166

Review 6.  Genetic risk factors and restenosis after percutaneous coronary interventions.

Authors:  A Kastrati; J Dirschinger; A Schömig
Journal:  Herz       Date:  2000-02       Impact factor: 1.443

7.  Early sign of atherosclerosis in slow coronary flow and relationship with angiotensin-converting enzyme I/D polymorphism.

Authors:  Halil Tanriverdi; Harun Evrengul; Hatice Mergen; Ceren Acar; Deniz Seleci; Omur Kuru; Seyhan Tanriverdi; Asuman Kaftan
Journal:  Heart Vessels       Date:  2007-01-26       Impact factor: 2.037

8.  A study of gene--environment interaction on the gene for angiotensin converting enzyme: a combined functional and population based approach.

Authors:  F A Sayed-Tabatabaei; A F C Schut; A Hofman; A M Bertoli-Avella; J Vergeer; J C M Witteman; C M van Duijn
Journal:  J Med Genet       Date:  2004-02       Impact factor: 6.318

Review 9.  Vascular injury in systemic sclerosis: angiotensin-converting enzyme insertion/deletion polymorphism.

Authors:  Cinzia Fatini; Serena Guiducci; Rosanna Abbate; Marco Matucci-Cerinic
Journal:  Curr Rheumatol Rep       Date:  2004-04       Impact factor: 4.592

10.  Angiotensin-converting enzyme gene and retinal arteriolar narrowing: the Funagata Study.

Authors:  Y Tanabe; R Kawasaki; J J Wang; T Y Wong; P Mitchell; M Daimon; T Oizumi; T Kato; S Kawata; T Kayama; H Yamashita
Journal:  J Hum Hypertens       Date:  2009-04-16       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.